Alkem looks alrightAlkem Laboratories Ltd. engages in the development, manufacture, and sale of pharmaceutical products. It produces branded generics, generic drugs, active pharmaceutical ingredient, and nutraceuticals.
Alkem Laboratories Ltd. CMP is 6039.55. The positive aspects of the company are Company with Low Debt, Company with Zero Promoter Pledge, Stocks Outperforming their Industry Price Change in the Quarter and MFs increased their shareholding last quarter. The Negative aspects of the company are High Valuation (P.E. = 35.2), Declining Net Cash Flow : Companies not able to generate net cash and Increasing Trend in Non-Core Income.
Entry can be taken after closing above 6105 Targets in the stock will be 6202 and 6315. The long-term target in the stock will be 6442. Stop loss in the stock should be maintained at Closing below 5818 or 5363 depending upon your risk taking ability.
Disclaimer: The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
